Clarity Pharmaceuticals (ASX:CU6) Expands Radiopharmaceutical Pipeline
Clarity Pharmaceuticals (ASX:CU6) unveils a novel radiopharmaceutical, SAR-bisFAP, enhancing cancer diagnosis and treatment potential.
The Hub of Australian Finance News
Clarity Pharmaceuticals (ASX:CU6) unveils a novel radiopharmaceutical, SAR-bisFAP, enhancing cancer diagnosis and treatment potential.
Magnis Energy Technologies Ltd outlines its compliance updates and the status of key agreements in response to ASX queries.
DEXUS (ASX:DXS) announces a distribution of AUD 0.19 for security holders, payable on 28 February 2025.
Carbonxt Group Limited (ASX:CG1) has achieved mechanical completion of its Kentucky plant, enhancing its capacity to meet activated carbon market demand.
Adisyn Ltd has completed due diligence for acquiring 2D Generation, enhancing its semiconductor technology capabilities for the generative AI market.
Dexus (ASX: DXS) reports a portfolio valuation decrease, mainly affecting its office assets, but shows resilience in the industrial sector.
Perpetual Resources Ltd (ASX: PEC) reports final assays from Isabella showing ultra high-grade spodumene up to 6.8% Li2O.
Hot Chili Limited (ASX:HCH) has reported a major copper-gold discovery from its La Verde project in Chile.
MetalsTech Limited (ASX:MTC) provides updates on the Sturec Gold Mine’s operations, maintenance, and identified mineralisation potential.
NTAW Holdings Limited withdraws FY25 guidance amid revenue shortfalls and risks breaching bank financial covenants.